179 related articles for article (PubMed ID: 35146989)
21. Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".
Gonzalez RS; Raza A; Propst R; Adeyi O; Bateman J; Sopha SC; Shaw J; Auerbach A
Arch Pathol Lab Med; 2021 May; 145(5):607-626. PubMed ID: 32886739
[TBL] [Abstract][Full Text] [Related]
22. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.
Oka N; Kasajima A; Konukiewitz B; Sakurada A; Okada Y; Kameya T; Weichert W; Ishikawa Y; Suzuki H; Sasano H; Klöppel G
Neuroendocrinology; 2020; 110(5):393-403. PubMed ID: 31422400
[TBL] [Abstract][Full Text] [Related]
23. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
24. Classification of neuroendocrine neoplasms: lights and shadows.
La Rosa S; Uccella S
Rev Endocr Metab Disord; 2021 Sep; 22(3):527-538. PubMed ID: 33169199
[TBL] [Abstract][Full Text] [Related]
25. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T
Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950
[TBL] [Abstract][Full Text] [Related]
26. [Pathology of neuroendocrine neoplasms].
Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
[TBL] [Abstract][Full Text] [Related]
27. The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.
Volante M; Righi L; Berruti A; Rindi G; Papotti M
Virchows Arch; 2011 Apr; 458(4):393-402. PubMed ID: 21344263
[TBL] [Abstract][Full Text] [Related]
28. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
[TBL] [Abstract][Full Text] [Related]
29. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
Delektorskaia VV; Kushliskiĭ NE
Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
[TBL] [Abstract][Full Text] [Related]
30. Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.
Ramage JK; Valle JW; Nieveen van Dijkum EJM; Sundin A; Pascher A; Couvelard A; Kloeppel G; ;
Neuroendocrinology; 2019; 108(1):45-53. PubMed ID: 30219817
[TBL] [Abstract][Full Text] [Related]
31. Does combination of "cold" and "hot" somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?
Sowa-Staszczak A; Stefanska A; Chrapczynski P; Trofimiuk-Müldner M; Szura M; Hubalewska-Dydejczyk A
Endocr J; 2017 Feb; 64(2):171-177. PubMed ID: 27853048
[TBL] [Abstract][Full Text] [Related]
32. [Classification of gastro-entero-pancreatic neuroendocrine tumors].
Perren A; Schmitt A; Komminoth P; Pavel M
Radiologe; 2009 Mar; 49(3):198-205. PubMed ID: 19224191
[TBL] [Abstract][Full Text] [Related]
33. Revised classification of neuroendocrine tumors of the lung, pancreas and gut.
Capella C; Heitz PU; Höfler H; Solcia E; Klöppel G
Digestion; 1994; 55 Suppl 3():11-23. PubMed ID: 7698533
[TBL] [Abstract][Full Text] [Related]
34. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).
de Mestier L; Cros J
Ann Endocrinol (Paris); 2019 Jun; 80(3):172-173. PubMed ID: 31064662
[No Abstract] [Full Text] [Related]
35. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
Iyoda A; Azuma Y; Sano A
Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
[TBL] [Abstract][Full Text] [Related]
36.
Binderup T; Knigge U; Johnbeck CB; Loft A; Berthelsen AK; Oturai P; Mortensen J; Federspiel B; Langer SW; Kjaer A
J Nucl Med; 2021 Jun; 62(6):808-815. PubMed ID: 33067340
[TBL] [Abstract][Full Text] [Related]
37. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
38. Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
40. [Chinese expert consensus on lung and thymus neuroendocrine neoplasms].
Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):989-1000. PubMed ID: 34695888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
